Genoveva Uzunova: Why It’s Time to Close the Sex Variable Gap in Healthcare
Genoveva Uzunova, Former Senior Staff Associate at Columbia University in the City of New York, shared a post on LinkedIn:
“Today marks Sex Diff Day and Mental Health Awareness Week – a perfect time to discuss a gap in our healthcare system:
Sex as a Biological Variable (SABV).
As both a psychiatrist and a genetherapy researcher, I’ve seen how ignoring sex differences, from brain stereotaxic coordinates in the lab to diagnostic scales in the psychiatry clinic, may lead to missed targets and missed diagnoses.
In this video, I explore why men’s depression often ‘masks’ as irritability, and why structural brain differences mean we must move toward truly precision psychiatry.
We cannot provide better care until we do better, sex-specific science.
We know that the brains of female mice have many neuroanatomical and gene expression differences with the brains of male mice, which may translate into different behaviors.
Diseases such as depression, anxiety, autism, Alzheimer’s disease, multiple sclerosis, Systemic lupus erythematosus (SLE), and breast cancer have higher rates in women than in men.
In connection with today, my dear Mom, Anelia Uzunova, published a letter in Nature in 1976 with her co-authors Estelle Ramey and Peter Ramwell, on the Effect of testosterone, sex and age on experimentally induced arterial thrombosis.
My views in this presentation are based on my professional experience and literature searches.
I have discussed many of them, particularly relating to gene therapy and depression, with my supervisors but have met with some resistance as this will complicate the studies and work.
When I researched brain gene therapies for neurodegenerative disorders, I measured the Bregma-Lambda distances in our four transgenic mouse strains and found differences between strains and males and females.”
Stay updated with Hemostasis Today.
-
Jun 4, 2026, 05:42Subramamyam Penubaku: Early Recognition and Risk-Based Management of Acute Pulmonary Embolism
-
Jun 4, 2026, 05:30Raghavendra Rao: Early Endothermal Ablation and Contemporary Management of Superficial Venous Thrombosis
-
Jun 4, 2026, 05:18Fouad Mikhail: Mechanical Thrombectomy and Anticoagulation in Intermediate-Risk Pulmonary Embolism
-
Jun 3, 2026, 17:18Giacomo Rossi: Cysteine and Gut Health – MIT Finds the Switch
-
Jun 3, 2026, 17:00Amin Ullah: Presence of RBCs of Unequal Sizes in a Peripheral Blood Smear – Anisocytosis of RBC
-
Jun 3, 2026, 16:59Jean Connors: Discussing Cancer-Associated Thrombosis at the Japanese Society of Thrombosis and Hemostasis
-
Jun 3, 2026, 16:54Ayush Bhowmik: Failed Drug Became the World’s Most Widely Used Blood Thinner
-
Jun 3, 2026, 16:13Salvador Payán Pernía: Arguing against a Significant Role for Erythropoietin Analogues in the Management of PRCA
-
Jun 3, 2026, 16:08Pedro Henrique Las Casas: How Anticoagulant Agents and Quercetin Influence Cancer Cell Procoagulant Activity